S. Muoio & CO. LLC purchased a new stake in iKang Healthcare Group Inc (NASDAQ:KANG) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 80,000 shares of the medical research company’s stock, valued at approximately $1,637,000. S. Muoio & CO. LLC owned 0.12% of iKang Healthcare Group as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. bought a new position in iKang Healthcare Group in the 1st quarter valued at about $147,000. Aperio Group LLC acquired a new stake in shares of iKang Healthcare Group during the 2nd quarter worth approximately $237,000. Trexquant Investment LP acquired a new stake in shares of iKang Healthcare Group during the 1st quarter worth approximately $362,000. Renaissance Technologies LLC acquired a new stake in shares of iKang Healthcare Group during the 4th quarter worth approximately $377,000. Finally, Quad Capital Management Advisors LLC acquired a new stake in shares of iKang Healthcare Group during the 1st quarter worth approximately $522,111,000. 52.42% of the stock is currently owned by institutional investors.

Several analysts recently issued reports on KANG shares. ValuEngine upgraded shares of iKang Healthcare Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 2nd. BidaskClub lowered shares of iKang Healthcare Group from a “hold” rating to a “sell” rating in a research report on Wednesday, July 11th. Finally, TheStreet downgraded shares of iKang Healthcare Group from a “c” rating to a “d+” rating in a research note on Wednesday, August 15th.

NASDAQ KANG traded up $0.28 during mid-day trading on Friday, reaching $17.13. 60,057 shares of the stock were exchanged, compared to its average volume of 280,096. iKang Healthcare Group Inc has a one year low of $13.15 and a one year high of $21.01. The company has a market capitalization of $1.17 billion, a PE ratio of 64.81 and a beta of 0.03. The company has a quick ratio of 0.65, a current ratio of 0.67 and a debt-to-equity ratio of 0.10.

iKang Healthcare Group (NASDAQ:KANG) last posted its quarterly earnings results on Thursday, June 21st. The medical research company reported ($0.49) earnings per share for the quarter. iKang Healthcare Group had a negative net margin of 3.07% and a positive return on equity of 4.67%. The company had revenue of $89.53 million during the quarter.

iKang Healthcare Group Profile

iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company operates in two segments, Medical Examinations and Other Medical Services, and Dental Services. It offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items.

Further Reading: What is Compound Annual Growth Rate (CAGR)?

Institutional Ownership by Quarter for iKang Healthcare Group (NASDAQ:KANG)

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.